THE NATIONAL INSTITUTE OF CARDIOLOGY INVITES YOU TO THE JOINT 21ST ENS@T AND 1ST COST-HARMONIS@TION MEETING

 

WARSAW, 28.09.2022 - 30.09.2022


All Posters presentation

What is the role of the CHCHCD2 apoptotic protein in adrenal tumorigenesis

ANNA ANGELOUSI
National and Kapodistrian University of Athens

Identification of PPARG as a molecular target in adrenal Cushing's syndrome

Riester Anna
LMU Munich

Metyrapone treatment in bilateral macronodular adrenal hyperplasia: a report of three cases

Carmen Aresta
Unit for Bone Metabolism Diseases and Diabetes, Istituto Auxologico Italiano, IRCCS, Milan, Italy;

Ferroptosis in adrenocortical carcinoma (ACC) and its role in modulating immune response

Triebig Alexandra
Department of Internal Medicine IV, LMU Hospital Munich, Munich, Germany

Mitotane side effects in the treatment of patients with adrenocortical carcinoma - a retrospective study.

Anja Barac Nekic
University Clinical Hospital Centre Zagreb, Department of Endocrinology and Diabetology, Zagreb, Croatia

ARMC5 as a possible regulator of acetylation in the adrenal cortex in partnership with SIRT1

Annabel Berthon
Cochin Institute in Paris, France

Long remission after immunotherapy for a patient with metastatic ACC

Maria Boudina
Department of Endocrinology, THEAGENIO CANCER HOSPITAL THESSALONIKI GREECE

Whole blood transcriptomic profile of Cushing’s syndrome

Roberta Armignacco
Université Paris Cité, CNRS UMR8104, INSERM U1016, Institut Cochin, Paris, France

Subtype-specific pattern of white blood cell differential in ACTH-independent endogenous hypercortisolism.

Mario Detomas
University Hospital of Würzburg

Wee1 as a new pharmacological target in adrenocortical carcinomas

Emanuela Esposito
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy; PhD Program in Experimental Medicine, University of Milan, Milan, Italy

Interaction of magnetic iron oxide nanoparticles with primary human monocytes and adrenocortical carcinoma cell lines

CONG HONG
Discipline of Pharmacology and Therapeutics, School of Medicine, National University of Ireland, Galway, Ireland

Prognostic value of pharmacogenetics of CYP450 in adrenocortical carcinoma

Giulia Cantini
Dept. Experimental and Clinical Biomedical Sciences, University of Florence

Intratumor heterogeneity of transcriptome profiles in adrenocortical tumors

Anne Jouinot
Institut Cochin

Identification of adrenocortical cancer-associated microRNAs in aging female mice exposed to lifelong calorie restriction

Nazim Arda Keles
Yeditepe University

Prospective assessment of body composition during adjuvant mitotane therapy – preliminary results of a pilot study

Otilia Kimpel
Division of Endocrinology and Diabetes, Dept. of Medicine, University Hospital, University of Würzburg, Germany

Development and characterisation of a three-dimensional cell culture model of Adrenocortical Carcinoma

Sarah Feely
The Discipline of Pharmacology and Therapeutics, Lambe Institute for Translational Research, School of Medicine, National University of Ireland Galway, Galway, Ireland.

Methylation status of p16INK4a tumor-suppressor gene in adrenocortical carcinoma: preliminary study

Bojana Kozik
Vinca Institute of Nuclear Sciences, University of Belgrade, Serbia

Early postoperative basal aldosterone and aldosterone in saline infusion test do not predict biochemical remission of primary aldosteronism after adrenalectomy

Ivana Kraljević
Department of Endocrinology, UHC Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia

Objective systemic response to immune checkpoint inhibition combined with interstitial high dose rate brachytherapy of liver metastases in refractory adrenocortical carcinoma

Matthias Kroiss
University Hospital Munich, Ludwig-Maximilians-Universität München, Department of Internal Medicine IV

Glucocorticoid receptor polymorphism BclI influences Quality of Life in Endogenous Cushing’s syndrome

Lara Feldkamp
Endocrinology in Charlottenburg, 10627 Berlin, Germany; Clinical Endocrinology CCM, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany

Role of Inflammation-Based Scores in Predicting Treatment Response in Advanced Adrenocortical Carcinoma

Alessandra Mangone
1 Department of Clinical Sciences and Community Health, University of Milan, Milan (Italy); 2 Endocrinology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan (Italy);3 Institute of Metabolism and System Research, University of Birmingham, Birmingham (UK)

Evaluation of the body mass index and 1 mg overnight dexamethasone suppression test cortisol levels association in patients with adrenal incidentalomas

Ljiljana Marina
Clinic for Endocrinology, Diabetes and Metabolic diseases, University Clinical Centre of Serbia

ARTIFICIAL INTELLIGENCE APPLICATIONS IN SUPPORT FOR RESEARCH INTO ADRENAL GLAND TUMOR MANAGEMENT

Jolanta Mizera-Pietraszko
Military University of Land Forces

The Prevalence and Clinical Features of Venous ThromboEmbolism in AdrenoCortical Carcinoma.A tertiary referral center retrospective study

Marta Laganà
Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia at ASST Spedali Civili, Brescia, Italy.

Sublethal hyperthermia decreases cellular proliferation and transiently disrupts steroidogenesis in adrenal cells

Nathan Mullen
Discipline of Pharmacology and Therapeutics, School of Medicine, University of Galway, Ireland 

Oncocytic adrenocortical neoplasm with malignant potential - long-term latent disease course despite years of systemic treatment discontinuation - case report

Marta Opalińska
Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Kraków, Poland

Dehydroepiandrosterone sulfate (DHEAS) as a sex specific diagnostic tool in patients with adrenal incidentalomas and (possible) autonomous cortisol secretion

Tijana Petkovic
Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Centre of Serbia

EPAS1-mutated paraganglioma and pheochromocytoma in patients with hemoglobinopathy

Maxence MANCINI
Université Paris Cité, PARCC, INSERM, France

Filamin A is a cancer suppressor factor in adrenocortical tumors and is correlated with a better prognosis

Erika Peverelli
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy; Endocrinology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy

Elevated SGPL1 expression is associated with increased metabolism in cells and decreased patient survival in adrenocortical carcinoma

Rathi Prasad
Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London

IMPACT OF ADJUVANT MITOTANE THERAPY ON THE HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ADRENOCORTICAL CARCINOMA

Soraya Puglisi
Department of Clinical and Biological Science, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy

PC12 cell morphology affects chromaffin cell fate and vulnerability to drugs

Hermine Mohr
Institute for Diabetes and Cancer, Helmholtz Centre Munich, Ingolstaedter Landstr.1, 85764 Neuherberg, GermanyJoint Heidelberg-IDC Translational Diabetes Program, Heidelberg University Hospital, 69120 Heidelberg, Germany

Recurrence of missed Adrenocortical Carcinoma in a patient with adrenalectomy for Cushing Syndrome

Aysha Sarwani
University Hospital Galway, Centre for Diabetes, Endocrinology and Metabolism, Galway, Ireland

Bilateral Adrenal Ablation in a patient with Primary Aldosteronism and Cushing Syndrome with Bilateral Adrenal Hyperplasia

Aysha Sarwani
University Hospital Galway, Centre for Diabetes, Endocrinology and Metabolism, Galway, Ireland

Magnetic iron oxide nanoparticles uptake into Adrenocortical Carcinoma

Anna Sorushanova
Discipline of Pharmacology and Therapeutics, School of Medicine, University of Galway, Galway, Ireland

Novel Tissue microRNA Combinations to Diagnose Adrenocortical Malignancy Based on Machine Learning Methods

Peter Turai
Department of Endocrinology, ENS@T Research Center of Excellence, Faculty of Medicine, Semmelweis University, H-1083 Budapest, HungaryDepartment of Internal Medicine and Oncology, Faculty of Medicine, Semmelweis University, H-1083 Budapest, HungaryMTA-SE Molecular Medicine Research Group, Eötvös Loránd Research Network, H-1083 Budapest, Hungary

Effect of mitotane on male gonadal function

Antonio Stigliano
Endocrinology, Sant'Andrea University Hospital Sapienza University of Rome, Rome, Italy

Effects of Osilodrostat and Metyrapone on steroidogenesis in adrenocortical H295R tumor cells in vitro

Louis Thomeret
INSERM U1016 - CNRS UMR8104, Institut Cochin, 75014 Paris, France

Validation of diagnostic and prognostic potential of PINK1, DLGAP5 and BUB1B expression patterns in adrenocortical tumors

Lidija Todorović
Vinca Institute of Nuclear Sciences - National Institute of the Republic of Serbia, University of Belgrade

NDUFA4L2: A Novel Therapeutic Target in pseudo-hypoxic Pheochromocytoma and Paraganglioma

Jintian Wang
Institute for Diabetes and Cancer, Helmholtz Zentrum München, Munich

Circular RNA expression analysis in adrenocortical tumors

Peter Turai
1 Department of Endocrinology, ENS@T Research Center of Excellence, Faculty of Medicine, Semmelweis University, H-1083 Budapest, Hungary2 Department of Internal Medicine and Oncology, Faculty of Medicine, Semmelweis University, H-1083 Budapest, Hungary3 MTA-SE Molecular Medicine Research Group, Eötvös Loránd Research Network, H-1083 Budapest, Hungary

Application of Artificial Intelligence techniques for the diagnosis of adrenal tumours

Saandra Amador

A series of Pheochromocytomas and Paragangliomas: Clinical and immunohistopathological characteristics

ANNA ANGELOUSI
National and Kapodistrian University of Athens

Effect of the exogenous stimulation on the steroidogenesis in patients with adrenal incidentalomas

Natalija Antić
Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Centre of Serbia, National Centre for Infertility and Endocrinology of Gender, Belgrade, Serbia

Trabectedin, an effective drug to counteract the invasiveness and metastasis formation in preclinical AdrenoCortical Carcinoma models

Andrea Abate
Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, 25123

SDH genotype-phenotype associations in PPGL/HNPGL

Jean-Pierre Bayley
Leiden University Medical Center

Head and neck PGL: a retrospective monocentric study

Letizia Canu
University of Florence

Succinate dehydrogenase mutation and pituitary adenoma: can in vivo 1H-Magnetic Resonance Spectroscopy unravel the link?

Lussey-Lepoutre Charlotte
Sorbonne University, nuclear medicine department, Pitié-Salpêtrière Hospital, Assistance -Publique Hôpitaux de Paris, Paris Cardiovascular Research Center (PARCC), Inserm U970, Paris, France

Targeted inhibition of the WEE1 kinase with adavosertib (AZD1775) alone or in combination with standard chemotherapies as a novel potential therapeutic strategy in advanced adrenocortical carcinoma.

Barbara Altieri
Division of Endocrinology and DiabetesUniversity Hospital, University of WürzburgWürzburg, Germany

Incidental Phaeochromocytomas – A Large Tertiary Centre Experience

Yasir Elhassan
Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom

DOCOR study (type 2 Diabetes, Obesity and hidden CORtisol excess): preliminary data

Vittoria Favero
Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy

Of rare and serious

Miriam Giordano Imbroll
Mater Dei Hospital Malta, University of Malta

Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension

Fabio Bioletto
Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Turin, Italy

The effect of omitting preoperative alpha-adrenergic blockade on hemodynamic instability during pheochromocytoma resection

Isabelle Holscher
Amsterdam University Medical Center (Amsterdam UMC), Amsterdam

Optimization of perioperative management of pheochromocytomas: results from a national survey on future clinical trial design

I. Holscher
Amsterdam University Medical Center (Amsterdam UMC), Amsterdam

Genetic aspects of pheochromocytoma and paraganglioma in children and adolescents

Ivana Jochmanová
1st Department of Internal Medicine, Pavol Jozef Šafárik University in Košice, Faculty of Medicine, and Teaching Hospital of Louis Pasteur in Košice, Tr. SNP 1, 04001 Košice

Interest of salivary cortisol and cortisone assays in HPLC-MS/MS after 1mg-dexamethasone suppression test for the screening of Cushing syndrome

Fidéline Bonnet-Serrano
Assistance Publique des Hôpitaux de Paris-Hôpital Cochin-UF d'HormonologieInstitut Cochin, INSERMU1016

Characteristics of patients with PPGLs in a Romanian cohort

Sofia Lider
National Institute of Endocrinology CI Parhon, Bucharest, Romania

The useful and efficient biochemical tool for assessment of insulin resistance in patients with adrenal incidentaloma

Ljiljana Marina
Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Centre of Serbia

Pulmonary embolism as the first manifestation of Cushing Syndrome in a young woman

Mari Minasyan
Department of Endocrinology, Jagiellonian University Medical College, Kraków, Poland

The different contribution of IGF1R, IR and IGF2R in mediating insulin-like growth factor 2 (IGF2) effects in adrenocortical carcinomas

rosa catalano
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy;

Severe bone pain as a first presentation leading to diagnosis of metastatic composite pheochromocytoma.

Mari Minasyan
Department of Endocrinology, Jagiellonian University Medical College, Kraków, Poland

Hypervascular Lesion in the Adrenal Gland: A Case Report

Katarina Mlekus Kozamernik
UMC Ljubljana

ARTIFICIAL INTELLIGENCE APPLICATIONS IN SUPPORT FOR RESEARCH INTO ADRENAL GLAND TUMOR MANAGEMENT

José Angel Montes Olguín
Tecnológico Nacional de México Campus Zacatecas Norte

Zona glomerulosa derived Klotho effect on aldosterone synthesis in young mice

Arezoo Daryadel
University Hospital Zurich (USZ) and University of Zurich (UZH), Department of Endocrinology, Diabetology and Clinical Nutrition, Switzerland.

Immunohistochemical tools to detect or validate variants in CSDE1 and NF1 genes in PPGL

Robert Ntihinyuzwa
INSERM / PARCC

Adrenal Cavernous Hemangioma Associated with Possible Autonomous Cortisol Secretion.

serena palmieri
Endocrinology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

PRECOR study (PREssure CORtisol): preliminary results

Chiara Parazzoli
Department of Medical Biotechnology and Translational Medicine, University of Milan, 20100 Milan, Italy

Steroid profiles in patients with primary aldosteronism associated with autonomous cortisol secretion validated by measurements of dexamethasone

Constantinescu Georgiana
Department of Internal Medicine III, University Hospital “Carl Gustav Carus”, Technische Universität Dresden, GermanyUniversity of Medicine and Pharmacy Gr. T. Popa Iasi

SUCCESSFUL TREATMENT OF PHEOCHROMOCYTOMA CRISIS WITH EMERGENCY SURGERY: A CASE REPORT

Matej Rakusa
Department of Endocrinology, Diabetology, and Metabolic Disease, University Medical Center Ljubljana

Adrenal and Juxta-Adrenal Schwannomas: A Single-Center Study

Stacey Rolak
Mayo Clinic

1,25 -hydroxyvitamin D3 receptor immunohistochemical status in human adrenal medulla and pheochromocytoma cells.

Ewelina Rzepka
Chair and Department of Endocrinology, Jagiellonian University Medical College, Cracow, Poland.

Insights from the Incidence of Primary Aldosteronism in Patients with Hypokalemia (IPAHK+) - Study

Sven Gruber
Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), Zurich Switzerland

Mesenteric paraganglioma with a late-onset metastases after delayed surgery.

Ewelina Rzepka
Chair and Department of Endocrinology, Jagiellonian University Medical College, Cracow, Poland.

The relationship between adrenal incidentalomas and Covid-19 mortality risk: Preliminary results

Emre Sedar Saygili
Canakkale Onsekiz Mart University Faculty of Medicine, Canakkale, Turkey

Radiological and clinical features of 150 patients with adrenal tumors in one university center

Rytis Stakaitis
Neuroscience Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania

Interaction of magnetic iron oxide nanoparticles with primary human monocytes and adrenocortical carcinoma cell lines

CONG HONG
Discipline of Pharmacology and Therapeutics, School of Medicine, University of Galway, Ireland

Familial Paraganglioma and Phaeochromocytoma: A Case Report from the West of Ireland

Micheal Troy
National University of Ireland, Galway

Profound changes in inflammatory and cardiovascular biomarkers in patients with ACS and CS

Grethe Åstrøm Ueland
Department of Medicine, Haukeland University Hospital, Bergen, Norway

Adrenal Cyst-Management Dilemma: Case Report

Cvetanka Volkanovska Ilijevska
University Clinic for Endocrinology, Diabetes and Metabolic Diseases, Medical Faculty, University Ss. Cyril and Methodius, Skopje, North Macedonia

Progesterone suppresses proliferation, migration and invasion in human adrenocortical carcinoma cell lines and xenografted zebrafish embryos.

Mariangela Tamburello
Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia in Brescia, Italy

Safety of Core-needle Biopsy in Pheochromocytoma and Paraganglioma: Systematic Review and Individual Patient Meta-Analysis

Liang Zhang
Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Only Guided Posters

Ferroptosis in adrenocortical carcinoma (ACC) and its role in modulating immune response

Triebig Alexandra
Department of Internal Medicine IV, LMU Hospital Munich, Munich, Germany

Whole blood transcriptomic profile of Cushing’s syndrome

Roberta Armignacco
Université Paris Cité, CNRS UMR8104, INSERM U1016, Institut Cochin, Paris, France

Prognostic value of pharmacogenetics of CYP450 in adrenocortical carcinoma

Giulia Cantini
Dept. Experimental and Clinical Biomedical Sciences, University of Florence

Development and characterisation of a three-dimensional cell culture model of Adrenocortical Carcinoma

Sarah Feely
The Discipline of Pharmacology and Therapeutics, Lambe Institute for Translational Research, School of Medicine, National University of Ireland Galway, Galway, Ireland.

Glucocorticoid receptor polymorphism BclI influences Quality of Life in Endogenous Cushing’s syndrome

Lara Feldkamp
Endocrinology in Charlottenburg, 10627 Berlin, Germany; Clinical Endocrinology CCM, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany

The Prevalence and Clinical Features of Venous ThromboEmbolism in AdrenoCortical Carcinoma.A tertiary referral center retrospective study

Marta Laganà
Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia at ASST Spedali Civili, Brescia, Italy.

EPAS1-mutated paraganglioma and pheochromocytoma in patients with hemoglobinopathy

Maxence MANCINI
Université Paris Cité, PARCC, INSERM, France

PC12 cell morphology affects chromaffin cell fate and vulnerability to drugs

Hermine Mohr
Institute for Diabetes and Cancer, Helmholtz Centre Munich, Ingolstaedter Landstr.1, 85764 Neuherberg, GermanyJoint Heidelberg-IDC Translational Diabetes Program, Heidelberg University Hospital, 69120 Heidelberg, Germany

Novel Tissue microRNA Combinations to Diagnose Adrenocortical Malignancy Based on Machine Learning Methods

Peter Turai
Department of Endocrinology, ENS@T Research Center of Excellence, Faculty of Medicine, Semmelweis University, H-1083 Budapest, HungaryDepartment of Internal Medicine and Oncology, Faculty of Medicine, Semmelweis University, H-1083 Budapest, HungaryMTA-SE Molecular Medicine Research Group, Eötvös Loránd Research Network, H-1083 Budapest, Hungary

NDUFA4L2: A Novel Therapeutic Target in pseudo-hypoxic Pheochromocytoma and Paraganglioma

Jintian Wang
Institute for Diabetes and Cancer, Helmholtz Zentrum München, Munich

Trabectedin, an effective drug to counteract the invasiveness and metastasis formation in preclinical AdrenoCortical Carcinoma models

Andrea Abate
Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, 25123

Targeted inhibition of the WEE1 kinase with adavosertib (AZD1775) alone or in combination with standard chemotherapies as a novel potential therapeutic strategy in advanced adrenocortical carcinoma.

Barbara Altieri
Division of Endocrinology and DiabetesUniversity Hospital, University of WürzburgWürzburg, Germany

Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension

Fabio Bioletto
Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Turin, Italy

Interest of salivary cortisol and cortisone assays in HPLC-MS/MS after 1mg-dexamethasone suppression test for the screening of Cushing syndrome

Fidéline Bonnet-Serrano
Assistance Publique des Hôpitaux de Paris-Hôpital Cochin-UF d'HormonologieInstitut Cochin, INSERMU1016

The different contribution of IGF1R, IR and IGF2R in mediating insulin-like growth factor 2 (IGF2) effects in adrenocortical carcinomas

rosa catalano
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy;

Zona glomerulosa derived Klotho effect on aldosterone synthesis in young mice

Arezoo Daryadel
University Hospital Zurich (USZ) and University of Zurich (UZH), Department of Endocrinology, Diabetology and Clinical Nutrition, Switzerland.

Steroid profiles in patients with primary aldosteronism associated with autonomous cortisol secretion validated by measurements of dexamethasone

Constantinescu Georgiana
Department of Internal Medicine III, University Hospital “Carl Gustav Carus”, Technische Universität Dresden, GermanyUniversity of Medicine and Pharmacy Gr. T. Popa Iasi

Insights from the Incidence of Primary Aldosteronism in Patients with Hypokalemia (IPAHK+) - Study

Sven Gruber
Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), Zurich Switzerland

Interaction of magnetic iron oxide nanoparticles with primary human monocytes and adrenocortical carcinoma cell lines

CONG HONG
Discipline of Pharmacology and Therapeutics, School of Medicine, University of Galway, Ireland

Progesterone suppresses proliferation, migration and invasion in human adrenocortical carcinoma cell lines and xenografted zebrafish embryos.

Mariangela Tamburello
Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia in Brescia, Italy

Oral presentations

Targeted Next-Generation Sequencing analysis of germline DNA in 150 patients with sporadic adrenocortical carcinoma

Salvatore Grisanti
Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, ASST Spedali Civili, Brescia, Italy

Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma

Minghao Li
University hospital, TU Dresden

Delta-like non-canonical Notch ligand 1 (DLK1)- expressing adrenocortical progenitor cells: role in adrenal turnover, remodeling and tumorigenesis in mice.

Katia Mariniello
Centre for EndocrinologyWilliam Harvey Research InstituteFaculty of Medicine and DentistryQueen Mary University of London

Hyposuccinylation as a new mechanism behind the development of DLST-mutated PPGLs

S. Mellid
1. Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain

Preclinical studies for the evaluation of targeted therapies and the identification of early non-invasive biomarkers of tumor response in Sdhb-mutated tumors

Sophie Moog
Université de Paris, PARCC INSERM UMR970, Paris, France

A retrospective study on the association between urine metanephrines and cardiometabolic risk in patients with nonfunctioning adrenal incidentaloma.

Mirko Parasiliti Caprino
University of Turin

Prognostic role of targeted methylation status in formalin-fixed samples of adrenocortical carcinoma

Cristina Ronchi
Institute of Metabolism and System Research University of Birmingham Birmingham (UK)

A case of long-term culture of a primary human adrenocortical carcinoma spheroid

C.L. 1,2 Viëtor
1 Department of Internal Medicine, sector Endocrinology, Erasmus Medical Center, Rotterdam, The Netherlands2 Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands

Mechanistic insights on pheochromocytomas and paragangliomas from patients with cyanotic congenital heart disease.

Carlota Arenillas
Gastrointestinal and Endocrine Tumors Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, C/Natzaret, 115-117, 08035 Barcelona, Spain.

Zebrafish modeling of SDHB-associated paragangliomas

Margo Dona
Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

Macrophages and fibroblasts of tumour microenvironment differently modulate aggressiveness of pheochromocytoma spheroids

serena martinelli
Department of Experimental and Clinical Biomedical Sciences, University of Florence, Italy

The Impact of the EPD-M Treatment on the Survival of Metastatic Adrenocortical Carcinoma Patients: A population-based study

Willemien Menke-van der Houven van Oordt
Department of Medical Onclogy, AmsterdamUMC location VUMC

Differential genomic and microenvironment profile in MAML3 fusions-related PPGLs

Maria Monteagudo
CNIO

Delta-like non-canonical Notch ligand 1 (DLK1) – a novel biomarker in adrenocortical carcinoma

James Pittaway
Barts and The London School of Medicine and Dentistry

Plasma succinate as a marker for SDHx mutations in PPGL

Susan Richter
University Hospital Carl Gustav Carus Dresden

Towards an understanding of the microenvironment of ACC: Impact of steroid hormones and driver pathways

Maier Tanja
Klinikum der LMU München

Single-nuclei transcriptome of human adrenocortical adenomas reveals novel insights into molecular mechanisms intrinsic to tumourigenesis and autonomous cortisol secretion.

Barbara Altieri
Division of Endocrinology and DiabetesUniversity Hospital, University of WürzburgWürzburg, Germany

CXCR4-directed [68Ga]Ga-PentixaFor PET/CT as a novel diagnostic modality in primary aldosteronism

Amir Hossein Chaman Baz
Radboudumc Nijmegen

Development of an adrenocortical cell model of calcium signaling modulation to decipher the molecular mechanisms responsible for primary aldosteronism.

Bakhta Fedlaoui
PARCC, INSERM, Université de Paris, Paris France

Use of Steroid Profiling Combined With Machine Learning for the Diagnosis of Autonomous Cortisol Secretion

jimmy masjkur
Uniklinikum Dresden

Adrenalectomy improves blood pressure and cardiac structure in patients with possible autonomous cortisol secretion: results of a RCT

Valentina Morelli
Department of Endocrine and Metabolic disease, Istituto Auxologico Italiano, IRCCS, Milan, Italy

Steroid and global metabolome in benign adrenal tumours with mild autonomous cortisol secretion: analysis by mass spectrometry and machine learning to understand metabolic risk

Alessandro Prete
1) Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK. 2) Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK. 3) Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

The gut microbiome in patients with Cushing’s syndrome is severely altered

German Rubinstein
LMU Klinikum, Medizinische Klinik und Poliklinik IV

Genome-wide association studies identify risk loci for primary aldosteronism and reveal new pathogenic mechanisms

Boulkroun Sheerazed
Université Paris Cité, Inserm, PARCC, F-75015 Paris, France

Proposition of an histopathological classification of Bilateral Macronodular Adrenal Disease (BMAD) and its correlation with ARMC5 and KDM1A mutations

Florian Violon
Institut Cochin

Cure rates and histopathological findings after anatomical versus functional method in diagnosis of unilateral primary aldosteronism

Marianna Viukari
Endocrinology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland